NCT01676688View on ClinicalTrials.gov

Safety Study of Alfalastin (Human Alpha-1 Antitrypsin) Administered at Home

CompletedOBSERVATIONAL
Enrollment

17

Participants

Timeline

Start Date

January 31, 2012

Primary Completion Date

September 30, 2012

Study Completion Date

October 31, 2012

Conditions
Alpha 1-Antitrypsin Deficiency
All Listed Sponsors
lead

Laboratoire français de Fractionnement et de Biotechnologies

INDUSTRY

NCT01676688 - Safety Study of Alfalastin (Human Alpha-1 Antitrypsin) Administered at Home | Biotech Hunter | Biotech Hunter